Sign in
4

Changes in Ownership

MAXCYTE, INC. Filed Acc 0001209191-23-042110

President and CEO sold 30,000 shares at an average $5.03 ($150,852)

  • President and CEO acquired 30,000 shares (option exercise)
  • Traded under a Rule 10b5-1 plan

From the SEC's structured data for this filing

Trades in this filing

Doerfler Douglas · President and CEO

Table I: Non-derivative

6 lines
Date Transaction Shares Price Value Owned after D/I
2023-07-10 Exercise or conversion : show line 1 in the form 10b5-1 +445 $0.04 $18 333,642 D
2023-07-10 Sale : show line 2 in the form 10b5-1 −445 $5.01 $2,229 333,197 D
2023-07-11 Exercise or conversion : show line 3 in the form 10b5-1 +12,798 $0.04 $512 345,995 D
2023-07-11 Sale : show line 4 in the form 10b5-1 −12,798 $5.04 $64,502 333,197 D
2023-07-12 Exercise or conversion : show line 5 in the form 10b5-1 +16,757 $0.04 $670 349,954 D
2023-07-12 Sale : show line 6 in the form 10b5-1 −16,757 $5.02 $84,120 333,197 D
Open-market sales · 30,000 sh · avg $5.03 · $150,852

Table II: Derivative

3 lines
Date Transaction Shares Owned after D/I
2023-07-10 Exercise or conversion : show line 7 in the form 10b5-1 Employee Stock Option (right to buy) −445 264,635 D
2023-07-11 Exercise or conversion : show line 8 in the form 10b5-1 Employee Stock Option (right to buy) −12,798 251,837 D
2023-07-12 Exercise or conversion : show line 9 in the form 10b5-1 Employee Stock Option (right to buy) −16,757 235,080 D
Loading xslF345X04/doc4.xml…